Profil
Mr. Jean-Pierre Cassan is an Independent Director at Cegedim SA, a Member at French Cardiology Association, a Member at Société Française de Cardiologie and a Vice President at Institut National de la Santé & de la Recherche Médicale.
He is on the Board of Directors at Cegedim SA. Mr. Cassan was previously employed as a Manager by Eratos Santé SARL, a Chairman & Chief Executive Officer by ASTRA France SA, a Chairman & Chief Executive Officer by AstraZeneca SAS, a Member by Fédération Françaises des Industries de Santé, a Vice Chairman by INSERM Transfert SA, a Vice President by Institut De Formation Des Industries De Santé, and a Vice Chairman by La Référence Formation des Industries de Santé.
He also served on the board at Agence Française de Sécurité Sanitaire des Produits de Santé and Fondation Coeur Et Recherche.
Postes actifs de Jean-Pierre Cassan
| Sociétés | Poste | Début |
|---|---|---|
| CEGEDIM | Directeur/Membre du Conseil | 08/01/2010 |
French Cardiology Association | Corporate Officer/Principal | - |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Corporate Officer/Principal | - |
Société Française de Cardiologie | Corporate Officer/Principal | - |
Anciens postes connus de Jean-Pierre Cassan
| Sociétés | Poste | Fin |
|---|---|---|
Institut De Formation Des Industries De Santé
Institut De Formation Des Industries De Santé Miscellaneous Commercial ServicesCommercial Services Provides training services to the pharmaceutical and health sectors | Corporate Officer/Principal | - |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and commercializes pharmaceutical products | Directeur Général | - |
INSERM Transfert SA
INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions. | Directeur/Membre du Conseil | - |
ASTRA France SA
ASTRA France SA Miscellaneous Commercial ServicesCommercial Services Provides business and management consultancy services | Directeur Général | - |
Fondation Coeur Et Recherche
Fondation Coeur Et Recherche Miscellaneous Commercial ServicesCommercial Services Operates an voluntary membership organization | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Cegedim SA
Cegedim SA Packaged SoftwareTechnology Services Develops practice, pharmacy and care center management software and drug database | Technology Services |
INSERM Transfert SA
INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions. | Finance |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Commercial Services |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and commercializes pharmaceutical products | Health Technology |
Société Française de Cardiologie | |
Agence Française de Sécurité Sanitaire des Produits de Santé | |
French Cardiology Association | |
Fédération Françaises des Industries de Santé
Fédération Françaises des Industries de Santé Fédération Françaises des Industries de Santé is a private company based in Boulogne-Billancourt, France. | |
Eratos Santé SARL | |
La Référence Formation des Industries de Santé | |
ASTRA France SA
ASTRA France SA Miscellaneous Commercial ServicesCommercial Services Provides business and management consultancy services | Commercial Services |
Fondation Coeur Et Recherche
Fondation Coeur Et Recherche Miscellaneous Commercial ServicesCommercial Services Operates an voluntary membership organization | Commercial Services |
Institut De Formation Des Industries De Santé
Institut De Formation Des Industries De Santé Miscellaneous Commercial ServicesCommercial Services Provides training services to the pharmaceutical and health sectors | Commercial Services |
















